Basecamp Research
PrivateLast Round
Series C
Sep 23, 2026
Est. Valuation
$800M
Total Funding Raised
$235M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Basecamp Research operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series C round in September 2026.
Basecamp Research is a biotechnology and artificial intelligence company that builds foundational AI models for biological design using a proprietary, ethically sourced database of natural biodiversity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Synthetic Data
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Basecamp Research Comparables
Compare Basecamp Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Profluent Bio | 86% | |
| Cradle | 85% | |
| Evozyne | 84% |
For institutional investors. Book with your work email.
Basecamp Research Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 23, 2026 | ||||
| VC Round | Jan 12, 2026 | ||||
| Series B | Oct 9, 2024 | ||||
| Series A | Dec 13, 2022 | ||||
| Seed | Aug 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Basecamp Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B, Series C |
| UK Department for Science, Innovation and Technology | Series C |
| Catalio Capital Management | Series C |
| Singular | Series C, Series B |
| Systemiq Capital | Series A |
| NATO Innovation Fund | Series C |
| Blue Horizon | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
$140M round led by S32
- Aug 21, 2026
Monthly visitors increased 50% MoM, reaching 12.4K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 24, 2026
As part of its funding round, Basecamp Research Ltd. adds Andy Conrad, S32 general partner and former CEO of Google’s life sciences company Verily, to its board of directors.
- is_developingSep 23, 2026
Basecamp Research Ltd. is building an AI system for therapeutic design in United Kingdom that uses biological data from beyond public databases to design proteins and genetic medicines, with six AI-designed therapeutic programs advancing.
- is_developingSep 23, 2026
Basecamp Research Ltd. is developing artificial intelligence models in Massachusetts designed to generate therapeutic candidates using biological data.
- receives_financingSep 23, 2026
Basecamp Research Ltd. announced a $140M Series C financing on Sep 23rd '26 in United Kingdom and Massachusetts, led by S32 with participation from Anthropic's Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, NVIDIA, PostScriptum, Redalpine, The Rockefeller Foundation, Singular, Sovereign AI and True Ventures, to train new EDEN models and advance AI-designed therapeutics toward clinical development.
- is_developingSep 23, 2026
On Sep 23rd '26, Basecamp Research Ltd. is developing in vivo cell therapies using its EDEN biological foundation model to reprogram patients’ cells inside the body.
For institutional investors. Book with your work email.
Basecamp Research Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Basecamp Research's valuation, stock price, and market status.
Is Basecamp Research a public or private company?
Basecamp Research is a private company.
What is the current stock price of Basecamp Research?
Basecamp Research is a private company, so its shares have no public market price. Caplight tracks Basecamp Research's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Basecamp Research worth (valuation)?
Basecamp Research's valuation is estimated at $800.0M based on funding round data.
Can I buy Basecamp Research stock?
Basecamp Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Basecamp Research's last funding round?
Basecamp Research's most recent funding round was Series C on September 23, 2026.
Who are the main investors in Basecamp Research?
Key investors in Basecamp Research include S32, Singular, Systemiq Capital, Systemiq, True Ventures.
Will Basecamp Research IPO soon?
No public IPO plans have been announced for Basecamp Research.
How can I track Basecamp Research secondary market activity?
Caplight tracks bids, offers, and trades in Basecamp Research's shares on secondary markets.